Literature DB >> 29715365

Evaluation of Automatically Quantified Foveal Avascular Zone Metrics for Diagnosis of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.

Yansha Lu1,2, Joseph M Simonett1, Jie Wang1, Miao Zhang1,3, Thomas Hwang1, Ahmed M Hagag1, David Huang1, Dengwang Li2, Yali Jia1.   

Abstract

Purpose: To describe an automated algorithm to quantify the foveal avascular zone (FAZ), using optical coherence tomography angiography (OCTA), and to compare its performance for diagnosis of diabetic retinopathy (DR) and association with best-corrected visual acuity (BCVA) to that of extrafoveal avascular area (EAA).
Methods: We obtained 3 × 3-mm macular OCTA scans in diabetic patients with various levels of DR and healthy controls. An algorithm based on a generalized gradient vector flow (GGVF) snake model detected the FAZ, and metrics assessing FAZ size and irregularity were calculated. We compared the automated FAZ segmentation to manual delineation and tested the within-visit repeatability of FAZ metrics. The correlations of two conventional FAZ metrics, two novel FAZ metrics, and EAA with DR severity and BCVA, as determined by Early Treatment Diabetic Retinopathy Study (ETDRS) charts, were assessed.
Results: Sixty-six eyes from 66 diabetic patients and 19 control eyes from 19 healthy participants were included. The agreement between manual and automated FAZ delineation had a Jaccard index > 0.82, and the repeatability of automated FAZ detection was excellent in eyes at all levels of DR severity. FAZ metrics that incorporated both FAZ size and shape irregularity had the strongest correlation with clinical DR grade and BCVA. Of all the tested OCTA metrics, EAA had the greatest sensitivity in differentiating diabetic eyes without clinical evidence of retinopathy, mild to moderate nonproliferative DR (NPDR), and severe NPDR to proliferative DR from healthy controls. Conclusions: The GGVF snake algorithm tested in this study can accurately and reliably detect the FAZ, using OCTA data at all DR severity grades, and may be used to obtain clinically useful information from OCTA data regarding macular ischemia in patients with diabetes. While FAZ metrics can provide clinically useful information regarding macular ischemia, and possibly visual acuity potential, EAA measurements may be a better biomarker for DR.

Entities:  

Mesh:

Year:  2018        PMID: 29715365      PMCID: PMC5958306          DOI: 10.1167/iovs.17-23498

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  44 in total

1.  Measurement of Foveal Avascular Zone Dimensions and its Reliability in Healthy Eyes Using Optical Coherence Tomography Angiography.

Authors:  Abtin Shahlaee; Maria Pefkianaki; Jason Hsu; Allen C Ho
Journal:  Am J Ophthalmol       Date:  2015-09-28       Impact factor: 5.258

2.  Snakes, shapes, and gradient vector flow.

Authors:  C Xu; J L Prince
Journal:  IEEE Trans Image Process       Date:  1998       Impact factor: 10.856

3.  Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.

Authors:  Akihiro Ishibazawa; Taiji Nagaoka; Atsushi Takahashi; Tsuneaki Omae; Tomofumi Tani; Kenji Sogawa; Harumasa Yokota; Akitoshi Yoshida
Journal:  Am J Ophthalmol       Date:  2015-04-18       Impact factor: 5.258

4.  Absence of foveal avascular zone demonstrated by laser scanning fluorescein angiography.

Authors:  B Sander; M Larsen; C Engler; H Lund-Andersen
Journal:  Acta Ophthalmol (Copenh)       Date:  1994-10

5.  Computational fluid dynamics assisted characterization of parafoveal hemodynamics in normal and diabetic eyes using adaptive optics scanning laser ophthalmoscopy.

Authors:  Yang Lu; Miguel O Bernabeu; Jan Lammer; Charles C Cai; Martin L Jones; Claudio A Franco; Lloyd Paul Aiello; Jennifer K Sun
Journal:  Biomed Opt Express       Date:  2016-11-04       Impact factor: 3.732

6.  Retinal ischemia in diabetic retinopathy.

Authors:  G H Bresnick; G De Venecia; F L Myers; J A Harris; M D Davis
Journal:  Arch Ophthalmol       Date:  1975-12

7.  Adaptive Optics Reveals Photoreceptor Abnormalities in Diabetic Macular Ischemia.

Authors:  Peter L Nesper; Fabio Scarinci; Amani A Fawzi
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

8.  Alterations to the Foveal Cone Mosaic of Diabetic Patients.

Authors:  Lucie Sawides; Kaitlyn A Sapoznik; Alberto de Castro; Brittany R Walker; Thomas J Gast; Ann E Elsner; Stephen A Burns
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-07-01       Impact factor: 4.799

9.  The effects of macular ischemia on visual acuity in diabetic retinopathy.

Authors:  Dawn A Sim; Pearse A Keane; Javier Zarranz-Ventura; Simon Fung; Michael B Powner; Elise Platteau; Catey V Bunce; Marcus Fruttiger; Praveen J Patel; Adnan Tufail; Catherine A Egan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

10.  Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy.

Authors:  Florentina J Freiberg; Maximilian Pfau; Juliana Wons; Magdalena A Wirth; Matthias D Becker; Stephan Michels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-04       Impact factor: 3.117

View more
  36 in total

1.  Within-subject assessment of foveal avascular zone enlargement in different stages of diabetic retinopathy using en face OCT reflectance and OCT angiography.

Authors:  Giselle Lynch; Jorge S Andrade Romo; Rachel Linderman; Brian D Krawitz; Shelley Mo; Amir Zakik; Joseph Carroll; Richard B Rosen; Toco Y P Chui
Journal:  Biomed Opt Express       Date:  2018-11-05       Impact factor: 3.732

2.  Three-dimensional structural and angiographic evaluation of foveal ischemia in diabetic retinopathy: method and validation.

Authors:  Bingjie Wang; Acner Camino; Shaohua Pi; Yukun Guo; Jie Wang; David Huang; Thomas S Hwang; Yali Jia
Journal:  Biomed Opt Express       Date:  2019-06-24       Impact factor: 3.732

3.  Ultra-Widefield Protocol Enhances Automated Classification of Diabetic Retinopathy Severity with OCT Angiography.

Authors:  FuPeng Wang; Steven S Saraf; Qinqin Zhang; Ruikang K Wang; Kasra A Rezaei
Journal:  Ophthalmol Retina       Date:  2019-11-09

4.  OCT angiography-based monitoring of neovascular regression on fibrovascular membrane after preoperative intravitreal conbercept injection.

Authors:  Zizhong Hu; Yun Su; Ping Xie; Lu Chen; Jiangdong Ji; Ting Feng; Shaowei Wu; Kang Liang; Qinghuai Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-05-03       Impact factor: 3.117

5.  OCT Angiography Assessment of Retinal Microvascular Changes in Diabetic Eyes in an Urban Safety-Net Hospital.

Authors:  Sawarin Laotaweerungsawat; Catherine Psaras; Xiuyun Liu; Jay M Stewart
Journal:  Ophthalmol Retina       Date:  2019-11-15

6.  Projection-Resolved Optical Coherence Tomographic Angiography of Retinal Plexuses in Retinitis Pigmentosa.

Authors:  Ahmed M Hagag; Jie Wang; Kevin Lu; Gareth Harman; Richard G Weleber; David Huang; Paul Yang; Mark E Pennesi; Yali Jia
Journal:  Am J Ophthalmol       Date:  2019-03-06       Impact factor: 5.258

7.  Fully automated geometric feature analysis in optical coherence tomography angiography for objective classification of diabetic retinopathy.

Authors:  David Le; Minhaj Alam; Bernadette A Miao; Jennifer I Lim; Xincheng Yao
Journal:  Biomed Opt Express       Date:  2019-04-22       Impact factor: 3.732

8.  Combination of optical coherence tomography (OCT) and OCT angiography increases diagnostic efficacy of Parkinson's disease.

Authors:  Jing Zou; Kangcheng Liu; Fangling Li; Yi Xu; Lu Shen; Huizhuo Xu
Journal:  Quant Imaging Med Surg       Date:  2020-10

9.  OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.

Authors:  Yi-Ting Hsieh; Minhaj Nur Alam; David Le; Chia-Chieh Hsiao; Chang-Hao Yang; Daniel L Chao; Xincheng Yao
Journal:  Ophthalmol Retina       Date:  2019-05-07

Review 10.  Quantitative optical coherence tomography angiography: A review.

Authors:  Xincheng Yao; Minhaj N Alam; David Le; Devrim Toslak
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.